Valuation : Femasys Inc.

Market Cap 23.28M 20.06M 18.99M 17.22M 32.3M 2.22B 32.46M 226M 86.75M 1.13B 87.44M 85.52M 3.58B P/E 2026 *
-1.08x
P/E 2027 * -1.59x
Enterprise Value 23.28M 20.06M 18.99M 17.22M 32.3M 2.22B 32.46M 226M 86.75M 1.13B 87.44M 85.52M 3.58B EV / Sales 2026 *
9.82x
EV / Sales 2027 * 2.61x
Free-Float
96.08%
Yield 2026 *
-
Yield 2027 * -
1 day+1.46%
1 week-6.71%
Current month-18.95%
1 month+18.30%
3 months-33.49%
6 months-74.73%
Current year-75.88%
1 week 2.6
Extreme 2.6
3.09
1 month 2.02
Extreme 2.0223
3.69
Current year 2.02
Extreme 2.0223
14.51
1 year 2.02
Extreme 2.0223
22.2
3 years 2.02
Extreme 2.0223
95
5 years 2.02
Extreme 2.0223
162
10 years 2.02
Extreme 2.0223
275
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2003
Director of Finance/CFO 58 27/02/2022
Chief Operating Officer 52 29/03/2026
Director TitleAgeSince
Chairman 58 31/12/2003
Chairman 74 05/07/2022
Director/Board Member 75 31/07/2005
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Buy

Chief Technology Officer

9,375 0.1166%
07/08/26 Buy

Chief Financial Officer

46,875 0.5832%
07/08/26 Buy

Founder

46,875 0.5832%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%-6.71%-64.55%-58.38% 23.28M
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.18%-5.24%-5.65%+1.16% 55.78B
Weighted average by Cap. -0.69%-4.90%-6.02%+10.83%

Financials

2026 *2027 *
Net sales 2.37M 2.04M 1.94M 1.75M 3.29M 227M 3.31M 22.98M 8.84M 115M 8.91M 8.71M 364M 8.94M 7.7M 7.29M 6.61M 12.4M 854M 12.46M 86.58M 33.29M 434M 33.56M 32.82M 1.37B
Net income -19.18M -16.53M -15.65M -14.18M -26.61M -1.83B -26.74M -186M -71.46M -932M -72.03M -70.45M -2.95B -22.84M -19.68M -18.63M -16.89M -31.69M -2.18B -31.85M -221M -85.11M -1.11B -85.78M -83.9M -3.51B
Net Debt - -
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
11/09/26 US$2.780 +1.46% 16,202
10/09/26 US$2.740 -3.18% 35,533
09/09/26 US$2.830 +5.60% 46,734
08/09/26 US$2.680 -10.07% 198,411
04/09/26 US$2.980 -2.61% 72,927
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.780USD
Average target price
14.33USD
Spread / Average Target
+415.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FEMY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!